跳至主要内容
临床试验/JPRN-jRCTc030190102
JPRN-jRCTc030190102招募中2 期

ong-term evaluation of efficacy and safety of Platlet-Rich Plasma for human musculoskeletal injury, defect, and delayed healing.

Funasaki Hiroki0 个研究点目标入组 25 人开始时间: 2019年9月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who have disorders of tendon attachment and ligament injury.
  • Patients who have written an informed consent.
  • Patients who have no bacterial infection.
  • Patients who are over 20 years old men and women.

排除标准

  • Patients who have bacterial infection including the injection site.
  • Patients who have a risk of affecting their general health in case of bacterial infection by this therapy.
  • Patients who have over 37 degrees of body temperature without using antipyretic or anti-inflammatory.
  • Patients who have open wound.
  • Patients who undergo an oral treatment.

研究者

发起方
Funasaki Hiroki

相似试验